LBA60 Evaluation of gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in metastatic pancreatic ductal adenocarcinoma: Results of the randomized phase III PRODIGE 65 - UCGI 36 - GEMPAX UNICANCER study.

Autor:	de la Fouchardiere, C.1 (AUTHOR), Malka, D.2 (AUTHOR), Chabaud, S.3 (AUTHOR), Raimbourg, J.4 (AUTHOR), Botsen, D.5 (AUTHOR), Launay, S.6 (AUTHOR), Evesque, L.7 (AUTHOR), Vienot, A.8 (AUTHOR), Perrier, H.9 (AUTHOR), Jary, M.10 (AUTHOR), Rinaldi, Y.11 (AUTHOR), Bergouignan, C. Coutzac12 (AUTHOR), Bachet, J-B.13 (AUTHOR), Neuzillet, C.14 (AUTHOR), Williet, N.15 (AUTHOR), Desgrippes, R.16 (AUTHOR), Brard, G.17 (AUTHOR), Lachaux, N.17 (AUTHOR), Bouche, O.18 (AUTHOR), Ghiringhelli, F.19 (AUTHOR)
Zdroj:	Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1426-S1426. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu